Abe, K., Higashi, K., Watabe, K., Kobayashi, A., Limwikrant, W., Yamamoto, K., Moribe, K., Effects of the PEG molecular weight of a PEG-lipid and cholesterol on PEG chain flexibility on liposome surfaces. Colloids Surf., A 474 (2015), 63–70.
Angius, F., Floris, A., Liposomes and MTT cell viability assay: an incompatible affair. Toxicol. in Vitro 29 (2015), 314–319.
Belletti, D., Tosi, G., Forni, F., Lagreca, I., Barozzi, P., Pederzoli, F., Vandelli, M.A., Riva, G., Luppi, M., Ruozi, B., PEGylated siRNA lipoplexes for silencing of BLIMP-1 in primary effusion lymphoma: in vitro evidences of antitumoral activity. Eur. J. Pharm. Biopharm. 99 (2015), 7–17.
Braeckmans, K., Buyens, K., Bouquet, W., Vervaet, C., Joye, P., De Vos, F., Plawinski, L., Doeuvre, L., Angles-Cano, E., Sanders, N.N., Demeester, J., De Smedt, S.C., Sizing nanomatter in biological fluids by fluorescence single particle tracking. Nano Lett. 10 (2010), 4435–4442.
Briuglia, M.L., Rotella, C., McFarlane, A., Lamprou, D.A., Influence of cholesterol on liposome stability and on in vitro drug release. Drug deliv. translat. res. 5 (2015), 231–242.
Buyens, K., De Smedt, S.C., Braeckmans, K., Demeester, J., Peeters, L., van Grunsven, L.A., de Mollerat du Jeu, X., Sawant, R., Torchilin, V., Farkasova, K., Ogris, M., Sanders, N.N., Liposome based systems for systemic siRNA delivery: stability in blood sets the requirements for optimal carrier design. J. Control. Release 158 (2012), 362–370.
Chang, J.T., Kuo, T.F., Chen, Y.J., Chiu, C.C., Lu, Y.C., Li, H.F., Shen, C.R., Cheng, A.J., Highly potent and specific siRNAs against E6 or E7 genes of HPV16- or HPV18-infected cervical cancers. Cancer Gene Ther. 17 (2010), 827–836.
Cheng, Y.W., Lee, H., Shiau, M.Y., Wu, T.C., Huang, T.T., Chang, Y.H., Human papillomavirus type 16/18 up-regulates the expression of interleukin-6 and antiapoptotic Mcl-1 in non-small cell lung cancer. Clin. Cancer Res. 14 (2008), 4705–4712.
Conde, J., Ambrosone, A., Hernandez, Y., Tian, F., McCully, M., Berry, C.C., Baptista, P.V., Tortiglione, C., de la Fuente, J.M., 15 years on siRNA delivery: beyond the state-of-the-art on inorganic nanoparticles for RNAi therapeutics. Nano Today 10 (2015), 411–532.
Dan, N., Danino, D., Structure and kinetics of lipid-nucleic acid complexes. Adv. Colloid Interf. Sci. 205 (2014), 230–239.
Das Neves, J., Rocha, C.M., Goncalves, M.P., Carrier, R.L., Amiji, M., Bahia, M.F., Sarmento, B., Interactions of microbicide nanoparticles with a simulated vaginal fluid. Mol. Pharm. 9 (2012), 3347–3356.
Das Neves, J., Araujo, F., Andrade, F., Michiels, J., Arien, K.K., Vanham, G., Amiji, M., Bahia, M.F., Sarmento, B., In vitro and ex vivo evaluation of polymeric nanoparticles for vaginal and rectal delivery of the anti-HIV drug dapivirine. Mol. Pharm. 10 (2013), 2793–2807.
Doorbar, J., Quint, W., Banks, L., Bravo, I.G., Stoler, M., Broker, T.R., Stanley, M.A., The biology and life-cycle of human papillomaviruses. Vaccine 30:S5 (2012), F55–F70.
Douglas, K.L., Piccirillo, C.A., Tabrizian, M., Cell line-dependent internalization pathways and intracellular trafficking determine transfection efficiency of nanoparticle vectors. Eur. J. Pharm. Biopharm. 68 (2008), 676–687.
Ensign, L.M., Tang, B.C., Wang, Y.Y., Tse, T.A., Hoen, T., Cone, R., Hanes, J., Mucus-penetrating nanoparticles for vaginal drug delivery protect against herpes simplex virus. Sci. Transl. Med., 4, 2012, 138ra179.
Foldvari, M., Weng Chen, D., Nafissi, N., Calderon, D., Narsineni, L., Rafiee, A., Non-viral gene therapy: gains and challenges of non-invasive administration methods. J. Control. Release, 2015 (in press).
Furst, T., Dakwar, G.R., Zagato, E., Lechanteur, A., Remaut, K., Evrard, B., Braeckmans, K., Piel, G., Freeze-dried mucoadhesive polymeric system containing pegylated lipoplexes: Towards a vaginal sustained released system for siRNA. J. Control. Release, 2016 (in press).
Furst, T., Dakwar, G.R., Zagato, E., Lechanteur, A., Remaut, K., Evrard, B., Braeckmans, K., Piel, G., Freeze-dried mucoadhesive polymeric system containing pegylated lipoplexes: towards a vaginal sustained released system for siRNA. J. Control. Release, 2016 (Submitted for publication).
Ghittoni, R., Accardi, R., Hasan, U., Gheit, T., Sylla, B., Tommasino, M., The biological properties of E6 and E7 oncoproteins from human papillomaviruses. Virus Genes 40 (2010), 1–13.
Gomes-Da-Silva, L., Fonseca, N., Moura, V., Pedroso de Lima, M., Simeos, S., Moreira, J.N., Lipid-based nanoparticles for siRNA delivery in cancer therapy: paradigms and challenges. Acc. Chem. Res. 45 (2012), 1163–1171.
Hama, S., Itakura, S., Nakai, M., Nakayama, K., Morimoto, S., Suzuki, S., Kogure, K., Overcoming the polyethylene glycol dilemma via pathological environment-sensitive change of the surface property of nanoparticles for cellular entry. J. Control. Release 206 (2015), 67–74.
Hill, A.B., Chen, M., Chen, C.-K., Pfeifer, B.A., Jones, C.H., Overcoming gene-delivery hurdles: physiological considerations for nonviral vectors. Trends Biotechnol. 34 (2015), 91–105.
Hirko, A., Tang, F.X., Hughes, J.A., Cationic lipid vectors for plasmid DNA delivery. Curr. Med. Chem. 10 (2003), 1185–1193.
Huth, U.S., Schubert, R., Peschka-Suss, R., Investigating the uptake and intracellular fate of pH-sensitive liposomes by flow cytometry and spectral bio-imaging. J. Control. Release 110 (2006), 490–504.
Jiang, M., Milner, J., Selective silencing of viral gene expression in HPV-positive human cervical carcinoma cells treated with siRNA, a primer of RNA interference. Oncogene 21 (2002), 6041–6048.
Junquera, E., Aicart, E., Recent progress in gene therapy to deliver nucleic acids with multivalent cationic vectors. Adv. Colloid Interf. Sci., 2015 (in press).
Kapoor, M., Burgess, D.J., Patil, S.D., Physicochemical characterization techniques for lipid based delivery systems for siRNA. Int. J. Pharm. 427 (2012), 35–57.
Kesharwani, P., Gajbhiye, V., Jain, N.K., A review of nanocarriers for the delivery of small interfering RNA. Biomaterials 33 (2012), 7138–7150.
Koltover, I., Salditt, T., Rädler, J.O., Safinya, C.R., An inverted hexagonal phase of cationic liposome–DNA complexes related to DNA release and delivery. Science 281 (1998), 78–81.
Lai, S.K., Wang, Y.Y., Hanes, J., Mucus-penetrating nanoparticles for drug and gene delivery to mucosal tissues. Adv. Drug Deliv. Rev. 61 (2009), 158–171.
Lechanteur, A., Furst, T., Evrard, B., Delvenne, P., Hubert, P., Piel, G., Development of anti-E6 pegylated lipoplexes for mucosal application in the context of cervical preneoplastic lesions. Int. J. Pharm. 483 (2015), 268–277.
Leus, N.G., Talman, E.G., Ramana, P., Kowalski, P.S., Woudenberg-Vrenken, T.E., Ruiters, M.H., Molema, G., Kamps, J.A., Effective siRNA delivery to inflamed primary vascular endothelial cells by anti-E-selectin and anti-VCAM-1 PEGylated SAINT-based lipoplexes. Int. J. Pharm. 459 (2014), 40–50.
Livak, K.J., Schmittgen, T.D., Analysis of relative gene expression data using real-time quantitative PCR and the 2(− delta delta C(T)) method. Methods 25 (2001), 402–408.
Masotti, A., Mossa, G., Cametti, C., Ortaggi, G., Bianco, A., Grosso, N.D., Malizia, D., Esposito, C., Comparison of different commercially available cationic liposome–DNA lipoplexes: parameters influencing toxicity and transfection efficiency. Colloids and surfaces. B, Biointerfaces 68 (2009), 136–144.
Naldini, L., Gene therapy returns to centre stage. Nature 526 (2015), 351–360.
Netsomboon, K., Bernkop-Schnurch, A., Mucoadhesive vs. mucopenetrating particulate drug delivery. Eur. J. Pharm. Biopharm. 98 (2015), 76–89.
Oliveira, A.C., Raemdonck, K., Martens, T., Rombouts, K., Simon-Vazquez, R., Botelho, C., Lopes, I., Lucio, M., Gonzalez-Fernandez, A., Real Oliveira, M.E., Gomes, A.C., Braeckmans, K., Stealth monoolein-based nanocarriers for delivery of siRNA to cancer cells. Acta Biomater. 25 (2015), 216–229.
Perrier, T., Saulnier, P., Fouchet, F., Lautram, N., Benoit, J.P., Post-insertion into lipid nanocapsules (LNCs): from experimental aspects to mechanisms. Int. J. Pharm. 396 (2010), 204–209.
Qu, M.-H., Zeng, R.-F., Fang, S., Dai, Q.-S., Li, H.-P., Long, J.-T., Liposome-based co-delivery of siRNA and docetaxel for the synergistic treatment of lung cancer. Int. J. Pharm. 474 (2014), 112–122.
Rabanel, J.M., Hildgen, P., Banquy, X., Assessment of PEG on polymeric particles surface, a key step in drug carrier translation. J. Control. Release 185 (2014), 71–87.
Rädler, J.O., Koltover, I., Salditt, T., Safinya, C.R., Structure of DNA–cationic liposome complexes: DNA intercalation in multilamellar membranes in distinct interhelical packing regimes. Science 275 (1997), 810–814.
Rajalingam, K., Sharma, M., Lohmann, C., Oswald, M., Thieck, O., Froelich, C.J., Rudel, T., Mcl-1 is a key regulator of apoptosis resistance in Chlamydia trachomatis-infected cells. PLoS One, 3, 2008, e3102.
Remaut, K., Lucas, B., Braeckmans, K., Demeester, J., De Smedt, S.C., Pegylation of liposomes favours the endosomal degradation of the delivered phosphodiester oligonucleotides. J. Control. Release 117 (2007), 256–266.
Resnier, P., Montier, T., Mathieu, V., Benoit, J.P., Passirani, C., A review of the current status of siRNA nanomedicines in the treatment of cancer. Biomaterials 34 (2013), 6429–6443.
Rodriguez-Gascon, A., del Pozo-Rodriguez, A., Solinis, M.A., Development of nucleic acid vaccines: use of self-amplifying RNA in lipid nanoparticles. Int. J. Nanomedicine 9 (2014), 1833–1843.
Rodriguez-Gascon, A., Del Pozo-Rodriguez, A., Isla, A., Solinis, M.A., Vaginal gene therapy. Adv. Drug Deliv. Rev. 92 (2015), 71–83.
Shi, F., Wasungu, L., Nomden, A., Stuart, M.C.A., Polushkin, E., Engbertsand, J.B.F.N., Hoekstra, D., Interference of poly(ethylene glycol)–lipid analogues with cationic-lipid-mediated delivery of oligonucleotides; role of lipid exchangeability and non-lamellar transitions. Biochem. J. 366 (2002), 333–341.
Shim, G., Kim, M.-G., Park, J.Y., Oh, Y.-K., Application of cationic liposomes for delivery of nucleic acids. Asian J. Pharm. Sci. 8 (2013), 72–80.
Smisterova, J., Wagenaar, A., Stuart, M.C., Polushkin, E., ten Brinke, G., Hulst, R., Engberts, J.B., Hoekstra, D., Molecular shape of the cationic lipid controls the structure of cationic lipid/dioleylphosphatidylethanolamine-DNA complexes and the efficiency of gene delivery. J. Biol. Chem. 276 (2001), 47615–47622.
Sokolova, V., Kozlova, D., Knuschke, T., Buer, J., Westendorf, A.M., Epple, M., Mechanism of the uptake of cationic and anionic calcium phosphate nanoparticles by cells. Acta Biomater. 9 (2013), 7527–7535.
Stanley, M.A., Genital human papillomavirus infections: current and prospective therapies. J. Gen. Virol. 93 (2012), 681–691.
Suk, J.S., Xu, Q., Kim, N., Hanes, J., Ensign, L.M., PEGylation as a strategy for improving nanoparticle-based drug and gene delivery. Adv. Drug Deliv. Rev. 99:A (2015), 28–51.
Vader, P., Crielaard, B.J., van Dommelen, S.M., van der Meel, R., Storm, G., Schiffelers, R.M., Targeted delivery of small interfering RNA to angiogenic endothelial cells with liposome–polycation–DNA particles. J. Control. Release 160 (2012), 211–216.
Wang, T., Upponi, J.R., Torchilin, V.P., Design of multifunctional non-viral gene vectors to overcome physiological barriers: dilemmas and strategies. Int. J. Pharm. 427 (2012), 3–20.
Wang, Y., Miao, L., Satterlee, A., Huang, L., Delivery of oligonucleotides with lipid nanoparticles. Adv. Drug Deliv. Rev. 87 (2015), 68–80.
Webb, M., Saxon, D.H., Wong, F., Lim, H., Wang, Z., Bally, M.B., Choi, L., Cullis, P.R., Mayer, L., Comparison of different hydrophobic anchors conjugated to poly(ethylene glycol): effects on the pharmacokinetics of liposomal vincristine. Biochim. Biophys. Acta 1372 (1998), 272–282.
Wu, S.Y., Chang, H.-I., Burgess, M., McMillan, N.A.J., Vaginal delivery of siRNA using a novel PEGylated lipoplex-entrapped alginate scaffold system. J. Control. Release 155 (2011), 418–426.
Wytrwal, M., Leduc, C., Sarna, M., Goncalves, C., Kepczynski, M., Midoux, P., Nowakowska, M., Pichon, C., Gene delivery efficiency and intracellular trafficking of novel poly(allylamine) derivatives. Int. J. Pharm. 478 (2014), 372–382.
Xia, Y., Tian, J., Chen, X., Effect of surface properties on liposomal siRNA delivery. Biomaterials 79 (2015), 56–68.
Zhang, T., Zhao, C., Luo, L., Zhao, H., Cheng, J., Xu, F., The expression of Mcl-1 in human cervical cancer and its clinical significance. Med. Oncol. 29 (2012), 1985–1991.
Zhou, Y., Zhang, C., Liang, W., Development of RNAi technology for targeted therapy — a track of siRNA based agents to RNAi therapeutics. J. Control. Release 193 (2014), 270–281.